Concepedia

Mohammad Rashidian

MR

32

Publications

3.1K

Citations

25

H-Index

1980

Active since

Affiliations

Harvard University(Current)

Dana-Farber Cancer Institute

Massachusetts Institute of Technology

Massachusetts General Hospital

Whitehead Institute for Biomedical Research

Mohammad Rashidian is an author at Harvard University specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1980–2025

32

Publications

32

Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas

Anushka Dongre, Mohammad Rashidian, Ferenc Reinhardt et al. · Cancer Research · 2017 · 393 citations · Full text

Lymphopenia during the COVID-19 infection: What it shows and what can be learned

Soheil Tavakolpour, Taha Rakhshandehroo, Erin X. Wei et al. · Immunology Letters · 2020 · 353 citations · Full text

, , +4

Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells

Mohammad Rashidian, Jessica R. Ingram, Michael Dougan et al. · The Journal of Experimental Medicine · 2017 · 244 citations · Full text

Noninvasive imaging of immune responses

Mohammad Rashidian, Edmund J. Keliher, Angelina M. Bilate et al. · Proceedings of the National Academy of Sciences · 2015 · 219 citations · Full text

, , +22

Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint Inhibition

Bram Priem, Mandy M. T. van Leent, Abraham J. P. Teunissen et al. · Cell · 2020 · 194 citations · Full text

, , +12

Rows per page

1–5 of 32